OncoCyte Corporation(OCX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCX OncoCyte Corporation

盘后交易 12-23 18:56:28 EST

2.21

+0.02

+0.68%

盘后2.14

-0.06-2.95%

16:26 EST

最高2.22	最低2.21	成交量9,992
今开2.22	昨收2.19	日振幅0.69%
总市值3,712万	流通市值1,383万	总股本1,684万
成交额2.22万	换手率0.16%	流通股本627.11万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCX","market":"US","secType":"STK","nameCN":"OncoCyte Corporation","latestPrice":2.205,"timestamp":1734987599999,"preClose":2.19,"halted":0,"volume":9992,"hourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.205,"latestTime":"16:26 EST","volume":74,"amount":158.36,"timestamp":1734989171603},"delay":0,"floatShares":6271134,"shares":16835247,"eps":-4.043766,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.015,"latestTime":"12-23 18:56:28 EST","open":2.22,"high":2.2201,"low":2.205,"amount":22174.6290936,"amplitude":0.006895,"askPrice":2.71,"askSize":100,"bidPrice":1.93,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.043766,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"adjPreClose":2.19,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.19,"preClose":2.19,"latestTime":"08:52 EST","volume":10,"amount":21.9,"timestamp":1734961968539},"postHourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.205,"latestTime":"16:26 EST","volume":74,"amount":158.36,"timestamp":1734989171603},"volumeRatio":0.162448,"impliedVol":4.3936,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/OCX/wiki","defaultTab":"wiki","newsList":[{"id":"2492844601","title":"Oncocyte Corporation盘中异动 早盘急速上涨6.79%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492844601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492844601?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:42","pubTimestamp":1734532975,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时42分，Oncocyte Corporation股票出现异动，股价快速拉升6.79%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.16%。其相关个股中，Prenetics Global Limited C/Wts 18/05/2027 、Oncocyte Corporation、燃石医学涨幅较大，Inotiv, Inc.、Applied Dna Sciences, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为4.22%、3.79%、0.65%，振幅较大的相关个股有Oncocyte Corporation、Applied Dna Sciences, Inc.、Ispecimen Inc.，振幅分别为8.14%、7.57%、6.80%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224255984cb2bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224255984cb2bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2490386475","title":"Oncocyte Corporation盘中异动 股价大跌6.80%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490386475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490386475?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:02","pubTimestamp":1733932945,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时02分，Oncocyte Corporation股票出现波动，股价快速下跌6.80%。截至发稿，该股报2.33美元/股，成交量1103股，换手率0.01%，振幅0.00%。Oncocyte Corporation股票所在的生命科学行业中，整体涨幅为0.32%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000225984b59e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000225984b59e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2489340792","title":"Oncocyte Corporation盘中异动 急速拉升5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489340792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489340792?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:19","pubTimestamp":1733498371,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时19分，Oncocyte Corporation股票出现异动，股价急速拉升5.65%。Oncocyte Corporation股票所在的生命科学行业中，整体涨幅为1.48%。其相关个股中，Psychemedics Corporation、23Andme Holding Co.、Veracyte, Inc.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Endra Life Sciences Inc.较为活跃，换手率分别为1.13%、1.09%、1.01%，振幅较大的相关个股有Neuronetics, Inc.、万基遗传、Psychemedics Corporation，振幅分别为16.72%、13.97%、10.15%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231932a1d98927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231932a1d98927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2489630304","title":"Oncocyte Corporation盘中异动 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489630304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489630304?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:02","pubTimestamp":1733410932,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时02分，Oncocyte Corporation股票出现异动，股价大幅下挫5.02%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.95%。其相关个股中，Grail, Inc.、Ispecimen Inc.、燃石医学涨幅较大，Applied Dna Sciences, Inc.、Mainz Biomed N.V.、Psychemedics Corporation较为活跃，换手率分别为3.12%、2.23%、1.31%，振幅较大的相关个股有Mainz Biomed N.V.、Applied Dna Sciences, Inc.、Grail, Inc.，振幅分别为15.30%、14.55%、9.83%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205230212ab600c71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205230212ab600c71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2486832876","title":"Oncocyte Corporation盘中异动 急速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486832876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486832876?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:16","pubTimestamp":1732720574,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时16分，Oncocyte Corporation股票出现波动，股价大幅下挫5.13%。截至发稿，该股报2.40美元/股，成交量2389股，换手率0.01%，振幅3.43%。Oncocyte Corporation股票所在的生命科学行业中，整体涨幅为1.21%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112723161498e44f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112723161498e44f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2486889755","title":"Oncocyte Corporation盘中异动 快速上涨5.68%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486889755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486889755?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:17","pubTimestamp":1732641423,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时17分，Oncocyte Corporation股票出现波动，股价快速上涨5.68%。截至发稿，该股报2.79美元/股，成交量3554股，换手率0.02%，振幅4.36%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为1.13%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112701170398e44ba3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112701170398e44ba3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2485234414","title":"Oncocyte Corporation盘中异动 临近午盘急速下挫5.09%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485234414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485234414?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:37","pubTimestamp":1732207066,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时37分，Oncocyte Corporation股票出现波动，股价大幅下跌5.09%。截至发稿，该股报2.61美元/股，成交量731股，换手率0.00%，振幅5.45%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.18%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122003746abd51c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122003746abd51c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2485129010","title":"Oncocyte Corporation盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485129010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485129010?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:49","pubTimestamp":1732128562,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时49分，Oncocyte Corporation股票出现异动，股价快速拉升5.10%。截至发稿，该股报2.68美元/股，成交量8791股，换手率0.05%，振幅5.69%。Oncocyte Corporation股票所在的生命科学行业中，整体涨幅为0.34%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112102492398e43cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112102492398e43cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2484677708","title":"Oncocyte Corporation2024财年第三财季实现净利润-13.49百万美元，同比减少107.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677708?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945634,"startTime":"0","endTime":"0","summary":"11月19日，Oncocyte Corporation公布财报，公告显示公司2024财年第三财季净利润为-13.49百万美元，同比减少107.86%；其中营业收入为115000.00美元，同比减少73.19%，每股基本收益为-0.98美元。从资产负债表来看，Oncocyte Corporation总负债60.51百万美元，其中短期债务1.28百万美元，资产负债比为1.17，流动比率为0.50。机构评级：截至2024年11月19日，当前有2家机构对Oncocyte Corporation目标价做出预测，其中目标均价为4.12美元，其中最低目标价为4.00美元，最高目标价为4.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000054a2435288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000054a2435288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX"],"gpt_icon":0},{"id":"2483857185","title":"Oncocyte Corporation盘中异动 股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483857185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483857185?lang=zh_cn&edition=full","pubTime":"2024-11-16 02:29","pubTimestamp":1731695360,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日02时29分，Oncocyte Corporation股票出现波动，股价急速跳水5.71%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为3.53%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Exagen Inc.、奎斯特诊疗涨幅较大，Ispecimen Inc.、Endra Life Sciences Inc.、T2 Biosystems, Inc.较为活跃，换手率分别为57.28%、20.53%、4.53%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prenetics Global Limited C/Wts 18/05/2027 、Endra Life Sciences Inc.，振幅分别为42.05%、21.43%、17.58%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116022920a23bcdb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116022920a23bcdb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2483335447","title":"Oncocyte Corporation盘中异动 下午盘股价大跌5.37%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483335447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483335447?lang=zh_cn&edition=full","pubTime":"2024-11-15 03:19","pubTimestamp":1731611968,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日03时19分，Oncocyte Corporation股票出现波动，股价大幅下跌5.37%。截至发稿，该股报2.78美元/股，成交量28.6639万股，换手率1.70%，振幅6.40%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为1.19%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111503192898e42b79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111503192898e42b79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2483788037","title":"Oncocyte Corporation盘中异动 早盘股价大跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483788037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483788037?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:11","pubTimestamp":1731510675,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时11分，Oncocyte Corporation股票出现波动，股价快速下跌6.33%。截至发稿，该股报2.81美元/股，成交量5496股，换手率0.03%，振幅4.00%。Oncocyte Corporation股票所在的生命科学行业中，整体涨幅为0.10%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231115971a6507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231115971a6507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2481940985","title":"Oncocyte Corporation盘中异动 早盘快速下跌5.82%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481940985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481940985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:43","pubTimestamp":1730904201,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时43分，Oncocyte Corporation股票出现波动，股价大幅下跌5.82%。截至发稿，该股报2.75美元/股，成交量3811股，换手率0.02%，振幅3.42%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.34%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224321971a4c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224321971a4c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2481607747","title":"OncoCyte Corp    预计每股亏损 44 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481607747","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481607747?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:16","pubTimestamp":1730902604,"startTime":"0","endTime":"0","summary":"   * OncoCyte Corp    预计将在11月7日公布截至2024年9月30日的业绩报告(估计)，季度收入将出现下降。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于加利福尼亚州尔湾市的公司的营收预计将从一年前的42.9万美元下降53.4%至20万美元。* LSEG 分析师对 OncoCyte 公司的平均预期是每股亏损 44 美分。* 华尔街对 OncoCyte Corp 的 12 个月目标价中位数为 4.13 美元，高于其上一次收盘价 2.92 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"OncoCyte Corp    预计每股亏损 44 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCX"],"gpt_icon":0},{"id":"2473103049","title":"Oncocyte Corporation盘中异动 急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473103049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473103049?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:31","pubTimestamp":1728307912,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时31分，Oncocyte Corporation股票出现异动，股价大幅拉升5.19%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.43%。其相关个股中，23Andme Holding Co.、Oncocyte Corporation、基因技术涨幅较大，T2 Biosystems, Inc.、Applied Dna Sciences, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为1.63%、1.50%、1.28%，振幅较大的相关个股有23Andme Holding Co.、Mdxhealth Sa、Neuronetics, Inc.，振幅分别为4.41%、2.68%、2.65%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072131529595c1d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072131529595c1d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2472573107","title":"Oncocyte Corporation盘中异动 急速下跌5.02%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472573107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472573107?lang=zh_cn&edition=full","pubTime":"2024-10-03 00:00","pubTimestamp":1727884819,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日00时00分，Oncocyte Corporation股票出现异动，股价快速下跌5.02%。截至发稿，该股报2.84美元/股，成交量1372股，换手率0.01%，振幅3.34%。Oncocyte Corporation股票所在的生命科学行业中，整体涨幅为0.35%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100300001998e3a3c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100300001998e3a3c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2469084129","title":"Oncocyte Corporation盘中异动 股价大跌5.39%报3.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469084129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469084129?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:00","pubTimestamp":1727118007,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时00分，Oncocyte Corporation股票出现异动，股价大幅下跌5.39%。截至发稿，该股报3.16美元/股，成交量6194股，换手率0.05%，振幅2.99%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.03%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924030007ab6564a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924030007ab6564a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","BK4139"],"gpt_icon":0},{"id":"2469677236","title":"Oncocyte Corporation盘中异动 股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469677236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469677236?lang=zh_cn&edition=full","pubTime":"2024-09-21 02:29","pubTimestamp":1726856955,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日02时29分，Oncocyte Corporation股票出现异动，股价大幅拉升5.67%。截至发稿，该股报3.17美元/股，成交量1.1217万股，换手率0.08%，振幅7.50%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为1.67%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921022916ab64ee3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921022916ab64ee3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0},{"id":"2460736341","title":"Oncocyte Corporation2024财年第二财季实现净利润-4.53百万美元，同比增加45.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736341","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736341?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:03","pubTimestamp":1723910639,"startTime":"0","endTime":"0","summary":"8月18日，Oncocyte Corporation公布财报，公告显示公司2024财年第二财季净利润为-4.53百万美元，同比增加45.62%；其中营业收入为104000.00美元，同比减少77.54%，每股基本收益为-0.36美元。从资产负债表来看，Oncocyte Corporation总负债52.02百万美元，其中短期债务1.03百万美元，资产负债比为1.44，流动比率为1.39。机构评级：截至2024年8月18日，当前有2家机构对Oncocyte Corporation目标价做出预测，其中目标均价为4.12美元，其中最低目标价为4.00美元，最高目标价为4.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061495a16774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061495a16774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX"],"gpt_icon":0},{"id":"2459542959","title":"Oncocyte Corporation盘中异动 临近收盘快速下挫5.13%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459542959","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459542959?lang=zh_cn&edition=full","pubTime":"2024-08-13 04:01","pubTimestamp":1723492873,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日04时01分，Oncocyte Corporation股票出现异动，股价大幅下跌5.13%。截至发稿，该股报2.96美元/股，成交量1.2678万股，换手率0.09%，振幅10.90%。Oncocyte Corporation股票所在的生命科学行业中，整体跌幅为0.96%。Oncocyte Corporation公司简介：OncoCyte Corp 专注于用于癌症早期检测的新型非侵入性液体活检诊断的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813040113aefe704a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813040113aefe704a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncocyte.com","stockEarnings":[{"period":"1week","weight":-0.056},{"period":"1month","weight":-0.2036},{"period":"3month","weight":-0.3443},{"period":"6month","weight":-0.2261},{"period":"1year","weight":-0.2316},{"period":"ytd","weight":-0.124}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oncocyte Corporation于2009年在加利福尼亚州注册成立，是Bio Time的一家拥有多数股权的子公司。该公司是一家精准诊断公司，专注于开发和商业化三个领域的专有测试：VitaGraft是一种基于血液的实体器官移植监测测试，DetermaIO是一种评估肿瘤微环境以预测对免疫疗法的反应的基因表达测试，DetermaCNI是一种基于血液的监测工具，用于监测癌症患者的治疗效果。该公司正在继续开发DetermaIO，这是一种具有前景数据的测试，支持其帮助识别可能对检查点抑制剂药物产生反应的患者的潜力。这类新药可调节免疫反应，在包括非小细胞肺癌（NSCLC）、三阴性乳腺癌（TNBC）在内的多种实体瘤类型中显示活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.363525},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.113305},{"month":3,"riseRate":0.777778,"avgChangeRate":0.030608},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.029763},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.014148},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.092504},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.111855},{"month":8,"riseRate":0.444444,"avgChangeRate":0.016115},{"month":9,"riseRate":0.444444,"avgChangeRate":0.040094},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.127503},{"month":11,"riseRate":0.444444,"avgChangeRate":0.049155},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.041466}],"exchange":"NASDAQ","name":"OncoCyte Corporation","nameEN":"OncoCyte Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OncoCyte Corporation(OCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供OncoCyte Corporation(OCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"OncoCyte Corporation,OCX,OncoCyte Corporation股票,OncoCyte Corporation股票老虎,OncoCyte Corporation股票老虎国际,OncoCyte Corporation行情,OncoCyte Corporation股票行情,OncoCyte Corporation股价,OncoCyte Corporation股市,OncoCyte Corporation股票价格,OncoCyte Corporation股票交易,OncoCyte Corporation股票购买,OncoCyte Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OncoCyte Corporation(OCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供OncoCyte Corporation(OCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}